Abstract
Seroprevalence rates are important indicators to the epidemiology of COVID-19 and the rates vary according to the population. In Palestine, there is lack of data on the the percentage of undiagnosed population with previous mild or asymptomatic COVID-19. The purpose of this study is to assess the seroprevalence rate in the Palestinian population residing in the West Bank. Blood samples were collected from 1319 adults from Palestinian households in the West Bank and 1136 individuals visiting laboratories for a routine checkup. Serological tests for the 2455 serum samples were done using an Immunoassay for the qualitative detection of antibodies against SARS-CoV-2. The random sample of Palestinians living in the West Bank yielded 0% seroprevalence with 95% CI [0,0.0036], while the lab referrals sample yielded 4 positive cases. Hence the estimated seroprevalence in this sample is 0.354% with 95% CI [0.0011,0096]. Our results indicate that seroprevalence persist low and is inadequate to provide herd immunity and emphasize the need to maintain health measures to keep the outbreak under control.Funding Statement: The study was funded by the Arab American University.Declaration of Interests: No authors reported disclosures.Ethics Approval Statement: Approval from National ethical committee was obtained (PHRC/HC/737/20). Written informed consent was obtained from the 1319 study participants and approvals were obtained from Medicare laboratories for samples to be tested.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
